Model DetailsEye - Harderian gland adenocarcinoma
Model Name |
Eye - Harderian gland adenocarcinoma | Strain |
CD-1 |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonyms |
Harderian gland adenocarcinoma • Harderian adenocarcinoma • Harderian gland, adenocarcinoma |
Strain Synonyms |
outbred CD-1 • Swiss CD-1® • CD1 nontransgenic • Charles River CD-1 • Swiss CD-1 • Crl:CD-1®(ICR) • outbred CD1 • (Swiss) CD-1 • CD1 • Crl:CD-1(ICR)BR • ICR Crj:CD-1 • random-bred Crl:CD-1(ICR)BR • CD-1 outbred • Crl:CD-1 (ICR) BR • Crj:CD-1(ICR) • ICR(CD-1) • Crl: CD-1 (ICR) BR • ICR |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Eye - Harderian gland | Male |
0.8% (1 of 129 mice) |
|
Baldrick P, Toxicol Pathol 2007;35(4):562-9 | |
| Eye - Harderian gland | Female |
0.8% (1 of 125 mice) |
|
Baldrick P, Toxicol Pathol 2007;35(4):562-9 | |
| Eye - Harderian gland | Female |
2.4% (3 of 125 mice) |
|
Baldrick P, Toxicol Pathol 2007;35(4):562-9 | |
| Eye - Harderian gland | Male |
0.1% (1 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| Lung | Male |
0.1% (1 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| Eye - Harderian gland | Female |
0.1% (1 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| Lung | Female |
0.1% (1 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| Eye - Harderian gland | Male |
0.4% (4 of 891 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Eye - Harderian gland | Female |
0.2% (2 of 890 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |